Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 186

1.

The Insect Peptide CopA3 Increases Colonic Epithelial Cell Proliferation and Mucosal Barrier Function to Prevent Inflammatory Responses in the Gut.

Kim DH, Hwang JS, Lee IH, Nam ST, Hong J, Zhang P, Lu LF, Lee J, Seok H, Pothoulakis C, Lamont JT, Kim H.

J Biol Chem. 2016 Feb 12;291(7):3209-23. doi: 10.1074/jbc.M115.682856. Epub 2015 Dec 11.

2.

Clostridium difficile Infection.

Leffler DA, Lamont JT.

N Engl J Med. 2015 Jul 16;373(3):287-8. doi: 10.1056/NEJMc1506004. No abstract available.

3.

Clostridium difficile infection.

Leffler DA, Lamont JT.

N Engl J Med. 2015 Apr 16;372(16):1539-48. doi: 10.1056/NEJMra1403772. Review. No abstract available.

PMID:
25875259
4.

Evidence-based management of gastrointestinal diseases.

Lamont JT.

Gastroenterol Rep (Oxf). 2015 Feb;3(1):1-2. doi: 10.1093/gastro/gou092. No abstract available.

5.

Overview of Clostridium difficile infection: implications for China.

Chen X, Lamont JT.

Gastroenterol Rep (Oxf). 2013 Nov;1(3):153-8. doi: 10.1093/gastro/got029. Epub 2013 Nov 4.

6.

Clostridium difficile infection: a worldwide disease.

Burke KE, Lamont JT.

Gut Liver. 2014 Jan;8(1):1-6. doi: 10.5009/gnl.2014.8.1.1. Epub 2014 Jan 13. Review.

7.

Fecal transplantation for recurrent Clostridium difficile infection in older adults: a review.

Burke KE, Lamont JT.

J Am Geriatr Soc. 2013 Aug;61(8):1394-8. doi: 10.1111/jgs.12378. Epub 2013 Jul 19. Review.

PMID:
23869970
8.

Unexpected discovery of massive liver echinococcosis. A clinical, morphological, and functional diagnosis.

Bonfrate L, Giuliante F, Palasciano G, Lamont JT, Portincasa P.

Ann Hepatol. 2013 Jul-Aug;12(4):634-41.

9.

Adenoma detection rates vary minimally with time of day and case rank: a prospective study of 2139 first screening colonoscopies.

Leffler DA, Kheraj R, Bhansali A, Yamanaka H, Neeman N, Sheth S, Sawhney M, Lamont JT, Aronson MD.

Gastrointest Endosc. 2012 Mar;75(3):554-60. doi: 10.1016/j.gie.2011.11.021.

PMID:
22341102
10.

Editorial: not so nosocomial anymore: the growing threat of community-acquired Clostridium difficile.

Leffler DA, Lamont JT.

Am J Gastroenterol. 2012 Jan;107(1):96-8. doi: 10.1038/ajg.2011.404.

PMID:
22218031
11.

The insect peptide coprisin prevents Clostridium difficile-mediated acute inflammation and mucosal damage through selective antimicrobial activity.

Kang JK, Hwang JS, Nam HJ, Ahn KJ, Seok H, Kim SK, Yun EY, Pothoulakis C, Lamont JT, Kim H.

Antimicrob Agents Chemother. 2011 Oct;55(10):4850-7. doi: 10.1128/AAC.00177-11. Epub 2011 Aug 1.

12.

Clostridium difficile toxin A decreases acetylation of tubulin, leading to microtubule depolymerization through activation of histone deacetylase 6, and this mediates acute inflammation.

Nam HJ, Kang JK, Kim SK, Ahn KJ, Seok H, Park SJ, Chang JS, Pothoulakis C, Lamont JT, Kim H.

J Biol Chem. 2010 Oct 22;285(43):32888-96. doi: 10.1074/jbc.M110.162743. Epub 2010 Aug 9.

13.

Asymptomatic colonization by Clostridium difficile in infants: implications for disease in later life.

Jangi S, Lamont JT.

J Pediatr Gastroenterol Nutr. 2010 Jul;51(1):2-7. doi: 10.1097/MPG.0b013e3181d29767. Review.

PMID:
20512057
14.

Persistent psychological or physical symptoms following endoscopic procedures: an unrecognized post-endoscopy adverse event.

Berzin TM, Blanco PG, Lamont JT, Sawhney MS.

Dig Dis Sci. 2010 Oct;55(10):2869-73. doi: 10.1007/s10620-010-1197-2.

PMID:
20393877
15.

A 69-year-old woman presenting to the hospital with 48 hours of abdominal pain and diarrhea.

Leffler DA, Lamont JT.

Clin Gastroenterol Hepatol. 2009 Oct;7(10):1046-8. doi: 10.1016/j.cgh.2009.05.024. Epub 2009 Jun 23. No abstract available.

PMID:
19500692
16.

Clostridium difficile toxin A binds colonocyte Src causing dephosphorylation of focal adhesion kinase and paxillin.

Kim H, Rhee SH, Pothoulakis C, LaMont JT.

Exp Cell Res. 2009 Nov 15;315(19):3336-44. doi: 10.1016/j.yexcr.2009.05.020. Epub 2009 May 27.

17.

Treatment of Clostridium difficile-associated disease.

Leffler DA, Lamont JT.

Gastroenterology. 2009 May;136(6):1899-912. doi: 10.1053/j.gastro.2008.12.070. Epub 2009 May 7. Review.

PMID:
19457418
18.

Clostridium difficile--more difficult than ever.

Kelly CP, LaMont JT.

N Engl J Med. 2008 Oct 30;359(18):1932-40. doi: 10.1056/NEJMra0707500. Review. No abstract available. Erratum in: N Engl J Med. 2010 Oct 14;363(16):1585.

PMID:
18971494
19.

gp96 is a human colonocyte plasma membrane binding protein for Clostridium difficile toxin A.

Na X, Kim H, Moyer MP, Pothoulakis C, LaMont JT.

Infect Immun. 2008 Jul;76(7):2862-71. doi: 10.1128/IAI.00326-08. Epub 2008 Apr 14.

20.

Inflammation and apoptosis in Clostridium difficile enteritis is mediated by PGE2 up-regulation of Fas ligand.

Kim H, Rhee SH, Pothoulakis C, Lamont JT.

Gastroenterology. 2007 Sep;133(3):875-86. Epub 2007 Jul 3.

PMID:
17854595
21.

Recurrent clostridium difficile.

Maroo S, Lamont JT.

Gastroenterology. 2006 Apr;130(4):1311-6. Review. No abstract available.

PMID:
16618421
22.

Clostridium difficile toxin A-induced colonocyte apoptosis involves p53-dependent p21(WAF1/CIP1) induction via p38 mitogen-activated protein kinase.

Kim H, Kokkotou E, Na X, Rhee SH, Moyer MP, Pothoulakis C, Lamont JT.

Gastroenterology. 2005 Dec;129(6):1875-88.

PMID:
16344056
23.

Genetically engineered probiotics: a new twist on an old remedy.

Taylor CP, LaMont JT.

Gastroenterology. 2005 May;128(5):1509-12. Review. No abstract available.

PMID:
15887131
24.

Clostridium difficile toxin B activates the EGF receptor and the ERK/MAP kinase pathway in human colonocytes.

Na X, Zhao D, Koon HW, Kim H, Husmark J, Moyer MP, Pothoulakis C, LaMont JT.

Gastroenterology. 2005 Apr;128(4):1002-11.

PMID:
15825081
25.

Clostridium difficile toxin A regulates inducible cyclooxygenase-2 and prostaglandin E2 synthesis in colonocytes via reactive oxygen species and activation of p38 MAPK.

Kim H, Rhee SH, Kokkotou E, Na X, Savidge T, Moyer MP, Pothoulakis C, LaMont JT.

J Biol Chem. 2005 Jun 3;280(22):21237-45. Epub 2005 Mar 14.

26.

Neuroendocrine Tumors of the Pancreas.

McLoughlin JM, Kuhn JA, Lamont JT.

Curr Treat Options Gastroenterol. 2004 Oct;7(5):355-364.

PMID:
15345206
27.

Screening virtual colonoscopy--ready for prime time?

Morrin MM, LaMont JT.

N Engl J Med. 2003 Dec 4;349(23):2261-4. Epub 2003 Dec 1. No abstract available.

PMID:
14657435
28.

Effect of chondroitinase ABC on purulent sputum from cystic fibrosis and other patients.

Khatri IA, Bhaskar KR, Lamont JT, Sajjan SU, Ho CK, Forstner J.

Pediatr Res. 2003 Apr;53(4):619-27. Epub 2003 Jan 15.

PMID:
12612214
29.

Selective killing of cancer cells by beta -lapachone: direct checkpoint activation as a strategy against cancer.

Li Y, Sun X, LaMont JT, Pardee AB, Li CJ.

Proc Natl Acad Sci U S A. 2003 Mar 4;100(5):2674-8. Epub 2003 Feb 21.

30.

Protective role of HSP72 against Clostridium difficile toxin A-induced intestinal epithelial cell dysfunction.

Liu TS, Musch MW, Sugi K, Walsh-Reitz MM, Ropeleski MJ, Hendrickson BA, Pothoulakis C, Lamont JT, Chang EB.

Am J Physiol Cell Physiol. 2003 Apr;284(4):C1073-82. Epub 2002 Dec 18.

31.

Microbial factors in inflammatory bowel disease.

Farrell RJ, LaMont JT.

Gastroenterol Clin North Am. 2002 Mar;31(1):41-62. Review.

PMID:
12122743
32.

Theodore E. Woodward Award. How bacterial enterotoxins work: insights from in vivo studies.

Lamont JT.

Trans Am Clin Climatol Assoc. 2002;113:167-80; discussion 180-1. Review.

33.

Non-antibiotic therapy for Clostridium difficile infection.

Banerjee S, Lamont JT.

Curr Opin Infect Dis. 2000 Jun;13(3):215-219.

PMID:
11964789
34.

Clostridium difficile toxin A triggers human colonocyte IL-8 release via mitochondrial oxygen radical generation.

He D, Sougioultzis S, Hagen S, Liu J, Keates S, Keates AC, Pothoulakis C, Lamont JT.

Gastroenterology. 2002 Apr;122(4):1048-57.

PMID:
11910356
35.

Mechanism of lovastatin-induced apoptosis in intestinal epithelial cells.

Agarwal B, Halmos B, Feoktistov AS, Protiva P, Ramey WG, Chen M, Pothoulakis C, Lamont JT, Holt PR.

Carcinogenesis. 2002 Mar;23(3):521-8.

PMID:
11895868
36.
37.

Nerves and Intestinal Mast Cells Modulate Responses to Enterotoxins.

Pothoulakis C, Castagliuolo I, LaMont JT.

News Physiol Sci. 1998 Apr;13:58-63.

PMID:
11390763
38.

Gastrointestinal problems in the chronically critically ill patient.

Sheth SG, LaMont JT.

Clin Chest Med. 2001 Mar;22(1):135-47. Review.

PMID:
11315452
39.

Saccharomyces boulardii stimulates intestinal immunoglobulin A immune response to Clostridium difficile toxin A in mice.

Qamar A, Aboudola S, Warny M, Michetti P, Pothoulakis C, LaMont JT, Kelly CP.

Infect Immun. 2001 Apr;69(4):2762-5.

40.
41.

Is successful triage of patients with upper-gastrointestinal bleeding possible without endoscopy?

Farrell RJ, Alsahli M, LaMont JT.

Lancet. 2000 Oct 14;356(9238):1289-90. No abstract available.

PMID:
11073012
42.

Unlocking the secrets of the porcelain vase.

LaMONT JT.

Gastroenterology. 2000 Nov;119(5):1397-9. Review. No abstract available.

PMID:
11054399
43.

Pathogenesis and clinical manifestations of Clostridium difficile diarrhea and colitis.

Farrell RJ, LaMont JT.

Curr Top Microbiol Immunol. 2000;250:109-25. Review. No abstract available.

PMID:
10981360
44.

The renaissance of probiotics and prebiotics.

LaMont JT.

Gastroenterology. 2000 Aug;119(2):291. No abstract available.

PMID:
10930362
45.

Clostridium difficile toxin A causes early damage to mitochondria in cultured cells.

He D, Hagen SJ, Pothoulakis C, Chen M, Medina ND, Warny M, LaMont JT.

Gastroenterology. 2000 Jul;119(1):139-50.

PMID:
10889163
46.

Treatment of gastrointestinal infections.

Banerjee S, LaMont JT.

Gastroenterology. 2000 Feb;118(2 Suppl 1):S48-67. Review. No abstract available.

PMID:
10868898
47.

p38 MAP kinase activation by Clostridium difficile toxin A mediates monocyte necrosis, IL-8 production, and enteritis.

Warny M, Keates AC, Keates S, Castagliuolo I, Zacks JK, Aboudola S, Qamar A, Pothoulakis C, LaMont JT, Kelly CP.

J Clin Invest. 2000 Apr;105(8):1147-56.

48.

Pathophysiology, diagnosis and treatment of Clostridium difficile infection.

Castagliuolo I, LaMont JT.

Keio J Med. 1999 Dec;48(4):169-74. Review.

49.

Virtual colonoscopy: a kinder, gentler colorectal cancer screening test?

Morrin MM, Farrell RJ, Kruskal JB, LaMont JT.

Lancet. 1999 Sep 25;354(9184):1048-9. No abstract available.

PMID:
10509490
50.

Cysteine-rich regions of pig gastric mucin contain von willebrand factor and cystine knot domains at the carboxyl terminal(1).

Turner BS, Bhaskar KR, Hadzopoulou-Cladaras M, LaMont JT.

Biochim Biophys Acta. 1999 Oct 6;1447(1):77-92.

PMID:
10500247

Supplemental Content

Loading ...
Support Center